Role of the basomedial hypothalamus in regulation of adiposity, food intake, and reproductive traits in the domestic fowl

Characterization of the AMP-activated protein kinase pathway in chickens

In mammals, AMP-activated protein kinase (AMPK) is involved in the regulation of cellular energy homeostasis and, on the whole animal level, in regulating energy balance and food intake. Because the chicken is a valuable experimental animal model and considering that a first draft of the chicken genome sequence has recently been completed, we were interested in verifying the genetic basis for the LKB1/AMPK pathway in chickens. We identified distinct gene homologues for AMPK alpha, beta and gamma subunits and for LKB1, MO25 and STRAD. Analysis of gene expression by RT-PCR showed that liver, brain, kidney, spleen, pancreas, duodenum, abdominal fat and hypothalamus from 3 wk-old broiler chickens preferentially expressed AMPK alpha-1, beta-2 and gamma-1 subunit isoforms. Heart predominantly expressed alpha-2, beta-2 and gamma-1, whereas skeletal muscle expressed alpha-2, beta-2 and gamma-3 preferentially. Moreover, the AMPK gamma-3 gene was only expressed in heart and skeletal muscle. Genes encoding LKB1, MO25 alpha, MO25 beta, and STRAD beta were expressed in all examined tissues, whereas STRAD alpha was expressed exclusively in brain, hypothalamus, heart and skeletal muscle. Alterations in energy status (fasting and refeeding) produced little significant change in AMPK subunit gene transcription. We also determined the level of phosphorylated (active) AMPK in different tissues and in different states of energy balance. Immunocytochemical analysis of the chicken hypothalamus showed that activated AMPK was present in hypothalamic nuclei involved in regulation of food intake and energy balance. Together, these findings suggest a functional LKB1/AMPK pathway exists in chickens similar to that observed in mammals.

Role of the ventromedial hypothalamus in prolactin-induced hyperphagia in ring doves

Prolactin (PRL) strongly stimulates feeding activity and body weight gain in ring doves, and of the brain loci tested to date, the ventromedial hypothalamus (VMH) is the most effective site of PRL action in promoting these changes. To determine if the VMH is essential for this response, we examined the effects of VMN destruction on spontaneous feeding and on changes in food intake induced by intracerebroventricular (i.c.v.) injections of PRL. Male birds were selectively destroyed by radiofrequency lesions (n = 6). A group of sham-lesioned males (n = 6) served as controls. Lesioned birds exhibited a transient increase in food intake that peaked around the seventh postoperative day and declined to baseline levels by day 12. In contrast to this pattern, body weights of lesioned birds increased in parallel with food intake, but remained elevated throughout the 3-week postoperative period. During the peak period of hyperphagia in the lesioned group, food intake and body weight increases were two to three times greater in lesioned birds than in controls. After postoperative feed intake had stabilized, each bird received 5 daily i.c.v. injections of ovine PRL. Food intake and body weight increased dramatically in both groups in response to PRL treatment, and no group differences were observed in response to magnitude. We conclude that VMH destruction strongly perturbs feeding and body weight regulation in doves. However, VMH integrity is not essential for the expression of PRL-induced hyperphagia.

Effects of bilateral basomedial hypothalamic lesions on feeding, fattiness, and reproductive functions in the White Leghorn hen

During the last three decades, syndromes caused by bilateral destruction of the basomedial hypothalamus (BMH) were extensively studied in cockerels but not in hens. In the present study bilateral electrolytic lesions in the BMH of White Leghorn (WL) hens produced two main sets of symptoms: (a) Obese, functionally castrated hen (OFC); and (b) Obese, laying hen (OL). Following the placement of the hypothalamic lesion, the OFC hens developed transient hyperphagia, that was followed by hypophagia. Weight gain was accelerated in both periods, and marked obesity developed. These hens had high hematocrit values, and atrophied ovary, oviduct, comb, and adenohypophysis. Plasma estrogen, and total lipids and liver weight were reduced in the OFC hens. In these hens, the lesioned area included the ventromedial hypothalamic nucleus (VMH), the mammillary nuclei, and in some birds also the arcuate nuclei, and the tuberal nucleus. The OL hens manifested transient hyperphagia that subsided into normophagia with the development of obesity. These hens were less obese than the OFC ones and showed normal reproductive traits. The lesioned area in the OL hens was limited to the VMH. Unlike functionally castrated cockerels, where the induced fattiness is accompanied with higher rate of lipogenesis, the OFC hen manifested a unique syndrome: increased fattiness with arrest in estrogen-dependent lipogenesis.

Avian telencephalon and body weight

The neurological mechanisms associated with weight gain in animals have been extensively studied in mammals, but relatively little investigation has been carried out in birds. As in mammals, it has been shown that lesion of the ventromedial nucleus of the hypothalamus leads to hyperphagia and obesity in several species of birds. Likewise, bilateral lesions of the lateral hypothalamus result in aphagia and weight loss. Therefore, at the level of the hypothalamus, control of body weight appears to be controlled by similar neurological mechanisms in all homeothermic species via modulation of the sympathetic nervous system. Because of the role of the mammalian striatum in body weight regulation, body weight data from various manipulative studies in chickens were analyzed to see if these areas play a role in avian body weight regulation. In the first study, cycloheximide, glutamate, or saline was injected intracerebrally into 1-day-old chicks. In the second study, 3-day-old chicks received surgical ablation of the neocortex or kainic acid-induced lesions of the paleostriatum. Decreased body weight was noted in chicks that received injections of cycloheximide or glutamate, or kainic acid-induced lesions. The disruption in body weight in Experiment 1 might have been due to neurochemical pathology thought to occur in the paleostriatum. In the second experiment, lesions of the neostriatum or hyperstriatum, analogous to the neocortex in mammals, did not produce a difference in weight gain compared to controls. This preliminary work with kainic acid lesions in the chicken paleostriatum demonstrates a significant long-term decrease in body weight. As in mammals, the basal ganglia may have a role in body weight regulation.

Identification, partial characterization, and hypothalamic distribution of kappa, mu, and delta opioid receptors in a passerine songbird (Junco hyemalis)

Brain tissues obtained from a passerine songbird (dark-eyed junco, Junco hyemalis) were used to identify and partially characterize central opioid receptors. We found that [3H]EKC (putative kappa ligand), [3H]DAMGO (putative mu ligand), and [3H]DPDPE and [3H]pCl-DPDPE (two putative delta ligands) bind to brain tissue preparations specifically, in a time-dependent fashion, and with a high affinity (Kd's < or = 5 nM). Binding sites are present at low concentrations (Bmax < 120 fmol/mg protein), and they are pharmacologically selective. In vitro autoradiography studies revealed a high density of delta receptors in hypothalamic regions (ventromedial and lateral hypothalamus) that regulate feeding behavior. Together with previous studies, these observations suggest that the central influence of opioids on avian food consumption depends on mechanisms located in hypothalamic regions.

The response of broilers' adiposity to testosterone after embryonic exposure to androgen and tamoxifen

1. The effects of early exposure of heavy breed (HB) chicks to an anti-oestrogen (tamoxifen--TAM) and to an androgen which cannot be aromatised (5 alpha-dihydrotestosterone--DHT) on subsequent adiposity and its response to testosterone were studied. 2. Embryonic TAM administration reduced adiposity in females but not in males at 8 weeks of age. Embryonic DHT produced similar responses but to a lesser extent. 3. Testosterone propionate (TP) administration during growth had no effect on adiposity in any of the treated groups but TP reduced adiposity in males which had been exposed to DHT at the embryonic stage.